Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease.
about
Colorectal cancer diagnosis: Pitfalls and opportunitiesDifferential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectivesTherapeutic efficacy of pH-dependent release formulation of mesalazine on active ulcerative colitis resistant to time-dependent release formulation: analysis of fecal calprotectin concentrationDiagnosis of Iron Deficiency in Inflammatory Bowel Disease by Transferrin Receptor-Ferritin Index.Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis.Recommendations for identifying Crohn's disease patients with poor prognosis.Deep remission in inflammatory bowel disease: looking beyond symptoms.Clinical aspects of mucosal healing in inflammatory bowel diseases: what is it and what is the real value for the everyday practice?European evidence based consensus for endoscopy in inflammatory bowel disease.Targeting TNF-α for the treatment of inflammatory bowel disease.C-reactive protein in Crohn's disease: how informative is it?Endoscopic scoring systems for inflammatory bowel disease: pros and cons.Role of biomarkers in the study and management of inflammatory bowel disease: a "nonsystematic" review.Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease.Understanding Endoscopic Disease Activity in IBD: How to Incorporate It into Practice.Noninvasive Markers of Disease Activity in Inflammatory Bowel Disease.Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapy.Small bowel imaging of inflammatory bowel diseaseHistological healing in inflammatory bowel disease: a still unfulfilled promise.Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease.Noninvasive diagnosis of small bowel Crohn's disease: direct comparison of bowel sonography and magnetic resonance enterography.Ulcerative colitis endoscopic index of severity is associated with long-term prognosis in ulcerative colitis patients treated with infliximab.Fecal Calprotectin More Accurately Predicts Endoscopic Remission of Crohn's Disease than Serological Biomarkers Evaluated Using Balloon-assisted Enteroscopy.No association between serum adenosine deaminase activity and disease activity in Crohn's disease.The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.Mucosal healing as a treatment for IBD?Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.Mucosal Healing in Ulcerative Colitis: A Comprehensive Review.Treat-to-target in Crohn's disease: Will transmural healing become a therapeutic endpoint?
P2860
Q26774105-D8D25BB9-12D8-4F46-B83B-F42B2A0FB602Q28085134-51CECC14-1853-4A8F-8FB6-35E31BF367ABQ34608415-CAB54DA3-7EA6-4A28-9B3A-5F9DEA96C24FQ35858042-FA2F6FC1-18D6-46C2-BE22-AA1F1910CFB5Q36578893-2D8EF737-D0CB-49DD-9C46-930007FEAB58Q36793729-DD69E48E-CC42-4186-9E50-003B88BA463CQ38068962-3280BE8A-F142-4F39-9F21-746C5889959EQ38077111-B6E5B1C9-F38D-40A3-ADC7-3F56B064D49DQ38144113-DD90CFA1-20F1-4C69-97D4-C9C8801B93EFQ38159096-8C0B0F51-243F-455D-9084-40C43E858793Q38160905-2B9498DE-6FF9-409D-870B-DF20649FDBC6Q38196441-3CE6400C-FE5C-4F46-84AD-954592E14E41Q38197726-C0EF0DB5-EA36-4284-B0E6-F6F47BEB669FQ38249415-2957954A-BD07-4AA6-913D-5C70DEABA84BQ38293774-37BCB2C1-2DF9-4917-A456-5FFB312EB5CEQ38694153-2F9A8AC9-2C8E-4354-87A4-9FC09CDCEDCCQ39464033-895004CE-7B76-4DCE-B3DB-7336FF591C66Q40295402-072C1B31-3135-42CD-9922-302103D7A6CCQ40926333-A3CE884E-9595-4D3C-ADC0-913FE1B6BCC5Q41807969-AC49FA59-C701-4BA8-9D3D-7E7D60DBF38CQ41891565-1A586712-0D23-44A3-8E9E-E0C0147D639FQ43240077-9414558D-2C33-4EDB-9FDA-2EFCE157D4D9Q44207443-5E1BCD7E-76A2-43B0-80F3-6AA1EBCEC500Q45288151-0ED36A37-2C0D-4AFD-A894-4199C9FEE113Q47851299-73006418-28FE-4687-B4D4-075649735648Q47940693-67120A20-7CB5-4480-BEFC-82D39EDB9619Q50587883-CA80AAA2-FBB5-4B0D-818D-C633A4B1D300Q51012059-8D5ABCFB-63F9-46EE-8920-D44E24B8C1C2Q51290054-7D98B17A-544B-4E3C-81A6-CE55F08C1397Q53564533-470B0561-171E-44A8-9677-0D1BCDA83224Q53815697-29D3113A-E4D1-42FC-B11E-004949BC9368Q58551550-9F14667C-52EF-4D6E-BEC2-4EDD1879C927
P2860
Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Results of the 2nd part Scient ...... in inflammatory bowel disease.
@en
Results of the 2nd part Scient ...... in inflammatory bowel disease.
@nl
type
label
Results of the 2nd part Scient ...... in inflammatory bowel disease.
@en
Results of the 2nd part Scient ...... in inflammatory bowel disease.
@nl
prefLabel
Results of the 2nd part Scient ...... in inflammatory bowel disease.
@en
Results of the 2nd part Scient ...... in inflammatory bowel disease.
@nl
P2093
P2860
P50
P1476
Results of the 2nd part Scient ...... in inflammatory bowel disease.
@en
P2093
Edouard Louis
Fabiana Castiglione
Gerald Fraser
Iris Dotan
Jon Florholmen
Jordi Rimola
Lissy de Ridder
Scientific Committee of the European Crohn's and Colitis Organization
Walter Fries
Xavier Hebuterne
P2860
P304
P356
10.1016/J.CROHNS.2011.07.003
P577
2011-08-11T00:00:00Z